Skip to main content

Table 4 Univariate survival analysis of clinical characteristics (OS)

From: Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma

Statistic

HR (95%CI)

p

Sex

  

Women vs. men

1.471(0.269–8.032)

0.66

Age

1.044(0.962–1.133)

0.3

Smoker

  

Yes vs. no

0.269(0.031–2.304)

0.23

Alcohol

  

Yes vs. no

0.034(0-134.656)

0.42

Pathological grade

  

Undifferentiated carcinoma vs.

differentiated carcinoma

0.682(0.125–3.725)

0.66

cStage

  

III vs. I/II

0.434(0.045–4.174)

0.47

IV vs. I/II

8.866(1.469–53.507)

0.02

Treg% in CD4+cells

2.203(0.686–7.077)

0.19

CD25 H Score

2.061(0.429–9.898)

0.37